Invesco’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $574K | Buy |
50,761
+10,957
| +28% | +$124K | ﹤0.01% | 3101 |
|
|
2025
Q1 | $459K | Buy |
39,804
+24,164
| +155% | +$279K | ﹤0.01% | 3173 |
|
|
2024
Q4 | $132K | Buy |
15,640
+1,083
| +7% | +$9.17K | ﹤0.01% | 3572 |
|
|
2024
Q3 | $169K | Buy |
14,557
+277
| +2% | +$3.21K | ﹤0.01% | 3534 |
|
|
2024
Q2 | $168K | Buy |
14,280
+308
| +2% | +$3.63K | ﹤0.01% | 3654 |
|
|
2024
Q1 | $166K | Buy |
13,972
+495
| +4% | +$5.87K | ﹤0.01% | 3668 |
|
|
2023
Q4 | $165K | Buy |
+13,477
| New | +$165K | ﹤0.01% | 3590 |
|
|
2023
Q2 | – | Sell |
-10,147
| Closed | -$79.8K | – | 3883 |
|
|
2023
Q1 | $79.8K | Sell |
10,147
-1,071
| -10% | -$8.42K | ﹤0.01% | 3702 |
|
|
2022
Q4 | $75.8K | Buy |
+11,218
| New | +$75.8K | ﹤0.01% | 3840 |
|
|
2021
Q4 | – | Sell |
-10,222
| Closed | -$178K | – | 4033 |
|
|
2021
Q3 | $178K | Sell |
10,222
-145,618
| -93% | -$2.54M | ﹤0.01% | 3805 |
|
|
2021
Q2 | $3.73M | Buy |
+155,840
| New | +$3.73M | ﹤0.01% | 2569 |
|
|
2020
Q2 | – | Sell |
-10,884
| Closed | -$83K | – | 3624 |
|
|
2020
Q1 | $83K | Buy |
+10,884
| New | +$83K | ﹤0.01% | 3541 |
|
|
2019
Q4 | – | Sell |
-11,257
| Closed | -$130K | – | 3614 |
|
|
2019
Q3 | $130K | Sell |
11,257
-247,416
| -96% | -$2.86M | ﹤0.01% | 3557 |
|
|
2019
Q2 | $5.73M | Sell |
258,673
-55,118
| -18% | -$1.22M | ﹤0.01% | 2096 |
|
|
2019
Q1 | $8.98M | Buy |
313,791
+37,268
| +13% | +$1.07M | ﹤0.01% | 1641 |
|
|
2018
Q4 | $5.46M | Buy |
+276,523
| New | +$5.46M | ﹤0.01% | 1885 |
|
|
2015
Q3 | – | Sell |
-54
| Closed | -$5K | – | 3859 |
|
|
2015
Q2 | $5K | Buy |
+54
| New | +$5K | ﹤0.01% | 4202 |
|